Mitochondrial abnormalities in tumor necrosis factor-α-induced heart failure are associated with impaired DNA repair activity

Circulation

Volumn 104, Issue 20, 2001, Pages 2492-2497

  Li, Yun You ^a   Chen, Dexi ^b   Watkins, Simon C ^a   Feldman, Arthur M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b LEGACY RESEARCH   (United States)

Author keywords

Heart failure; Metabolism; Molecular biology; Structure

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; CYTOCHROME C OXIDASE; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; DNA GLYCOSYLTRANSFERASE; GENE PRODUCT; LACTATE DEHYDROGENASE; LACTIC ACID; MITOCHONDRIAL DNA; PYRUVIC ACID; SUCCINATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; ELECTRON MICROSCOPY; GENE MUTATION; GLYCOLYSIS; HEART DILATATION; HEART FAILURE; HEART MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0035856534     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4501.098944     Document Type: Article

References (35)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
2. Mitochondrial cardiomyopathy
3. Mitochondrial DNA deletions in dilated cardiomyopathy: A clinical study employing endomyocardial sampling
4. Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy
5. Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy
6. Mitochondrial defects in cardiomyopathy and neuromuscular disease
7. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease
8. Sequence and organization of the human mitochondrial genome
9. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction
10. Normal oxidative damage to mitochondrial and nuclear DNA is extensive
11. Mutagenesis by 8-oxoguanine: An enemy within
12. Repair of alkylation and oxidative damage in mitochondrial DNA
13. Mitochondrial DNA repair pathways
14. DNA glycosylases in the base excision repair of DNA
15. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α
16. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines
17. Age-associated increase in 8-oxo-deoxyguanosine glycosylase/AP lyase activity in rat mitochondria
18. Cytochemistry and immunocytochemistry of mitochondria in tissue sections
19. Purity and stability of pyruvate and α-ketoglutarate
20. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure
21. Some statistical methods useful in circulation research
22. Clinical aspects of mitochondrial disorders
23. Human aging is associated with various point mutations in tRNA genes of mitochondrial DNA
24. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts
25. Cardiac involvement in mitochondrial diseases: A study on 17 patients with documented mitochondrial DNA defects
26. Mitochondrial DNA maintenance in vertebrates
27. Repair of 8-oxodeoxyguanosine lesions in mitochondrial DNA depends on the oxoguanine DNA glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial DNA of OGGl-defective mice
28. How complex is a respiratory complex?
29. Cytochrome oxidase immunohistochemistry: Clues for genetic mechanisms
30. Morphometric comparison of mitochondria and myofibrils of cardiomyocytes between hypertrophic and dilated cardiomyopathies
31. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy
32. Cytochrome c-dependent activation of caspase-3 by tumor necrosis factor requires induction of the mitochondrial permeability transition
33. Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium
34. Tissue mitochondrial DNA changes: A stochastic system
35. Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy